Residency · Orange, CA
Sponsored by University of California (Irvine)
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Journal of hepatology · 2023 · 2,696 citations · Timothy Morgan
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Hepatology (Baltimore, Md.) · 2023 · 2,397 citations · Timothy Morgan
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
The New England journal of medicine · 2024 · 923 citations · Nataliya Mar
The TRIPOD-LLM reporting guideline for studies using large language models.
Nature medicine · 2025 · 345 citations · Amy Moreno
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.
Annals of hepatology · 2024 · 542 citations · Timothy Morgan
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
The New England journal of medicine · 2021 · 1,404 citations · Lanny Hsieh, Alpesh Amin
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · 404 citations · Sheetal Desai
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Warren Chow